Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-Blind Study of the Safety, Pharmacokinetics and Pharmacodynamics of Escalating Repeat Doses of GSK249320 in Patients With Stroke

NCT00833989 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT00833989
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00833989 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-Blind Study of the Safety, Pharmacokinetics and Pharmacodynamics of Escalating Repeat Doses of GSK249320 in Patients With Stroke
Lead sponsor
GlaxoSmithKline
Phase
Phase 2
Overall status
Completed
Start date
July 8, 2009
Completion date
January 31, 2011
Enrollment
42 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

ischaemic attack, transient